Acta Scientific Cancer Biology (ASCB) (ISSN: 2582-4473)

Editorial Volume 7 Issue 3

Precision Therapy in Oncology

Mallik Singaraju*

Radiation Oncology, Continental Hospital, India

*Corresponding Author: Mallik Singaraju, Radiation Oncology, Continental Hospital, India.

Received: February 20, 2023; Published: April 01, 2023

Cancer is second most common cause of death in the world. As the technology is advancing, the number of newly diagnosed cancer cases are on raise. Especially, in advanced stage. A decade back, the treatment for advanced cancers was primarily by chemotherapeutic agents. But now, targeted therapies are becoming increasingly popular.

References

Citation

Citation: Mallik Singaraju. “Mutational Screening and Prenatal Diagnosis of β-thalassemia in Pakistani Families" Acta Scientific Cancer Biology 7.3 (2023): 01-02.

Copyright

Copyright: © 2023 Mallik Singaraju. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Last Date to Submit Articles
    Journal accepting all the types of Articles for upcoing issue by on/before July 30, 2025
  • Issue of Publication Certificate
    Publication Certificate will be issued to the author after Online publication of an Article
  • Best Article
    One Article will be selected as Best Article from all the Articles of the corresponding Issue, once the issue released, and honored with A Best Article Certificate

Contact US